Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy
- PMID: 27924722
- DOI: 10.2174/1573399812666161207123007
Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy
Abstract
Background: Diabetic nephropathy (DN) is one of the foremost causes of mortality in diabetic patients as a result of increased urinary albumin excretion (UAE) rate and compromised renal function.
Introduction: Determination of increased excretion of albumin in urine chiefly attribute to the onset and progression of DN. However, due to certain limitations of albuminuria, the search for more sensitive, specific and reliable renal biomarkers is required for early prediction of DN.
Methods: Bibliographic investigation was made to scrutinize the data reporting relevant biomarkers associated with DN and may be used to predict the onset and progression of nephropathy.
Result and conclusion: Optimization of biomarkers for a clinical situation requires a prospective validation in large numbers of patients with diabetic nephropathy and needs to be performed in different critically ill populations.
Keywords: Albuminuria; albumin; biomarkers; diabetic nephropathy; diagnostic method; emerging biomarkers.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.J Bras Nefrol. 2019 Oct-Dec;41(4):509-517. doi: 10.1590/2175-8239-JBN-2018-0200. J Bras Nefrol. 2019. PMID: 30897192 Free PMC article.
-
Diabetic nephropathy: traditional to proteomic markers.Clin Chim Acta. 2013 Jun 5;421:17-30. doi: 10.1016/j.cca.2013.02.019. Epub 2013 Feb 26. Clin Chim Acta. 2013. PMID: 23485645 Review.
-
Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.J Proteomics. 2019 Feb 20;193:205-216. doi: 10.1016/j.jprot.2018.10.010. Epub 2018 Oct 24. J Proteomics. 2019. PMID: 30366120 Clinical Trial.
-
[Early detection of diabetic nephropathy].Arq Bras Endocrinol Metabol. 2008 Apr;52(3):442-51. doi: 10.1590/s0004-27302008000300004. Arq Bras Endocrinol Metabol. 2008. PMID: 18506269 Review. Portuguese.
-
Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.Mol Cell Biochem. 2015 Oct;408(1-2):25-35. doi: 10.1007/s11010-015-2479-y. Epub 2015 Jun 24. Mol Cell Biochem. 2015. PMID: 26104579
Cited by
-
Effects of valsartan combined with α-lipoic acid on renal function in patients with diabetic nephropathy: a systematic review and meta-analysis.BMC Endocr Disord. 2021 Aug 31;21(1):178. doi: 10.1186/s12902-021-00844-0. BMC Endocr Disord. 2021. PMID: 34465338 Free PMC article.
-
Global research hotspots and trends in oxidative stress-related diabetic nephropathy: a bibliometric study.Front Endocrinol (Lausanne). 2025 Jan 10;15:1451954. doi: 10.3389/fendo.2024.1451954. eCollection 2024. Front Endocrinol (Lausanne). 2025. PMID: 39866738 Free PMC article.
-
Ameliorative effect of Cephalandra indica homeopathic preparation in STZ induced diabetic nephropathy rats.J Ayurveda Integr Med. 2019 Oct-Dec;10(4):255-261. doi: 10.1016/j.jaim.2017.07.010. Epub 2018 Nov 16. J Ayurveda Integr Med. 2019. PMID: 30455071 Free PMC article.
-
Clinical value of free ubiquitin in the identification of diabetic nephropathy in patients with type 2 diabetes mellitus and preliminary exploration of its protective effect.BMC Nephrol. 2025 Jul 17;26(1):395. doi: 10.1186/s12882-025-04219-8. BMC Nephrol. 2025. PMID: 40676522 Free PMC article.
-
The Profile and Function of Gut Microbiota in Diabetic Nephropathy.Diabetes Metab Syndr Obes. 2021 Oct 19;14:4283-4296. doi: 10.2147/DMSO.S320169. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34703261 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical